Anti-TXND5/ TXNDC5/ ENDOPDI functional antibody

Anti-TXND5/ TXNDC5/ ENDOPDI functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to TXNDC5/TXNDC5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1665-Ab-1/ GM-Tg-hg-SE1665-Ab-2Anti-Human TXNDC5 monoclonal antibodyHuman
GM-Tg-rg-SE1665-Ab-1/ GM-Tg-rg-SE1665-Ab-2Anti-Rat TXNDC5 monoclonal antibodyRat
GM-Tg-mg-SE1665-Ab-1/ GM-Tg-mg-SE1665-Ab-2Anti-Mouse TXNDC5 monoclonal antibodyMouse
GM-Tg-cynog-SE1665-Ab-1/ GM-Tg-cynog-SE1665-Ab-2Anti-Cynomolgus/ Rhesus macaque TXNDC5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1665-Ab-1/ GM-Tg-felg-SE1665-Ab-2Anti-Feline TXNDC5 monoclonal antibodyFeline
GM-Tg-cang-SE1665-Ab-1/ GM-Tg-cang-SE1665-Ab-2Anti-Canine TXNDC5 monoclonal antibodyCanine
GM-Tg-bovg-SE1665-Ab-1/ GM-Tg-bovg-SE1665-Ab-2Anti-Bovine TXNDC5 monoclonal antibodyBovine
GM-Tg-equg-SE1665-Ab-1/ GM-Tg-equg-SE1665-Ab-2Anti-Equine TXNDC5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1665-Ab-1/ GM-Tg-hg-SE1665-Ab-2; GM-Tg-rg-SE1665-Ab-1/ GM-Tg-rg-SE1665-Ab-2;
GM-Tg-mg-SE1665-Ab-1/ GM-Tg-mg-SE1665-Ab-2; GM-Tg-cynog-SE1665-Ab-1/ GM-Tg-cynog-SE1665-Ab-2;
GM-Tg-felg-SE1665-Ab-1/ GM-Tg-felg-SE1665-Ab-2; GM-Tg-cang-SE1665-Ab-1/ GM-Tg-cang-SE1665-Ab-2;
GM-Tg-bovg-SE1665-Ab-1/ GM-Tg-bovg-SE1665-Ab-2; GM-Tg-equg-SE1665-Ab-1/ GM-Tg-equg-SE1665-Ab-2
Products NameAnti-TXNDC5 monoclonal antibody
Formatmab
Target NameTXNDC5
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TXNDC5 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1665-Ag-1Recombinant multi-species TXND5/ TXNDC5/ ENDOPDI protein


    Target information

    Target IDGM-SE1665
    Target NameTXNDC5
    Gene ID81567,105245,100362805,695213,100683583,101098632,615027,100061945
    Gene Symbol and SynonymsENDOPDI,ERP46,HCC-2,HCC2,PC-TRP,PDIA15,STRF8,TXNDC5,UNQ364
    Uniprot AccessionQ8NBS9
    Uniprot Entry NameTXND5_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000239264
    Target ClassificationN/A

    The target: TXNDC5, gene name: TXNDC5, also named as ENDOPDI, ERP46, HCC-2, HCC2, PDIA15, STRF8, UNQ364. This gene encodes a member of the disulfide isomerase (PDI) family of endoplasmic reticulum (ER) proteins that catalyze protein folding and thiol-disulfide interchange reactions. The encoded protein has an N-terminal endoplasmic reticulum (ER)-signal sequence, three catalytically active thioredoxin domains and a C-terminal ER-retention sequence. Its expression is induced by hypoxia and its role may be to protect hypoxic cells from apoptosis. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring upstream BLOC1S5 gene. [provided by RefSeq, Dec 2016].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.